Suppression of adjuvant arthritis in rats by induction of oral tolerance to mycobacterial 65-kDa heat shock protein
- PMID: 8921951
- DOI: 10.1002/eji.1830261116
Suppression of adjuvant arthritis in rats by induction of oral tolerance to mycobacterial 65-kDa heat shock protein
Abstract
Oral administration of mycobacterial 65-kDa heat shock protein (HSP) given daily for 5 days prior to immunization with Mycobacterium tuberculosis (Mt) suppressed the development of adjuvant arthritis (AA) in rats. AA was significantly suppressed by 30 and 300 micrograms HSP, and variably by 0.3, 3 micrograms or 1 mg. Histological analysis of joint samples obtained from control and test rats confirmed the suppression of AA in the fed group. Feeding Mt or hen egg lysozyme (HEL) failed to affect AA, indicating that the suppression was HSP specific. The oral administration of 30 micrograms HSP decreased both delayed-type hypersensitivity (DTH) reactions and proliferative responses to HSP and Mt. In addition, the proliferation of lymph node cells (LNC) from Mt-sensitized rats was inhibited by the addition of spleen cells (SPC) from HSP-fed animals, possibly by the secretion of transforming growth factor (TGF)-beta. Spleen cells obtained from tolerized donors were capable of transferring the tolerance to naive recipients. These results demonstrate that feeding HSP is an effective way to suppress AA and that the suppression of AA may be mediated by regulatory T cells generated following oral administration of mycobacterial 65-kDa HSP.
Similar articles
-
Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen.J Immunol. 1990 Oct 15;145(8):2489-93. J Immunol. 1990. PMID: 2120332
-
Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope.Arthritis Rheum. 2002 Jul;46(7):1937-46. doi: 10.1002/art.10366. Arthritis Rheum. 2002. PMID: 12124879
-
Treatment of adjuvant-induced arthritis by oral administration of mycobacterial Hsp65 during disease.Arthritis Rheum. 2000 Dec;43(12):2694-702. doi: 10.1002/1529-0131(200012)43:12<2694::AID-ANR9>3.0.CO;2-E. Arthritis Rheum. 2000. PMID: 11145027
-
Heat shock protein 60 and adjuvant arthritis: a model for T cell regulation in human arthritis.Springer Semin Immunopathol. 2003 Aug;25(1):47-63. doi: 10.1007/s00281-003-0128-7. Springer Semin Immunopathol. 2003. PMID: 12904891 Review.
-
Heat-shock protein T-cell epitopes trigger a spreading regulatory control in a diversified arthritogenic T-cell response.Immunol Rev. 1998 Aug;164:169-74. doi: 10.1111/j.1600-065x.1998.tb01218.x. Immunol Rev. 1998. PMID: 9795774 Review.
Cited by
-
Inhibition of adjuvant-induced arthritis by nasal administration of novel synthetic peptides from heat shock protein 65.BMC Musculoskelet Disord. 2014 Jul 25;15:253. doi: 10.1186/1471-2474-15-253. BMC Musculoskelet Disord. 2014. PMID: 25059987 Free PMC article.
-
Treating arthritis by immunomodulation: is there a role for regulatory T cells?Rheumatology (Oxford). 2010 Sep;49(9):1632-44. doi: 10.1093/rheumatology/keq130. Epub 2010 May 12. Rheumatology (Oxford). 2010. PMID: 20463189 Free PMC article. Review.
-
Role of heat shock proteins in protection from and pathogenesis of infectious diseases.Clin Microbiol Rev. 1999 Jan;12(1):19-39. doi: 10.1128/CMR.12.1.19. Clin Microbiol Rev. 1999. PMID: 9880473 Free PMC article. Review.
-
Inhibition of acid ceramidase regulates MHC class II antigen presentation and suppression of autoimmune arthritis.Cytokine. 2020 Nov;135:155219. doi: 10.1016/j.cyto.2020.155219. Epub 2020 Jul 29. Cytokine. 2020. PMID: 32738771 Free PMC article.
-
Expression of Mycobacterium leprae HSP65 in tobacco and its effectiveness as an oral treatment in adjuvant-induced arthritis.Transgenic Res. 2011 Apr;20(2):221-9. doi: 10.1007/s11248-010-9404-7. Epub 2010 Jun 6. Transgenic Res. 2011. PMID: 20526808
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources